Genome-wide Linkage and Association Analyses Implicate FASN in Predisposition to Uterine Leiomyomata
- 1 October 2012
- journal article
- research article
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 91 (4), 621-628
- https://doi.org/10.1016/j.ajhg.2012.08.009
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker2010
- Global signatures of protein and mRNA expression levelsMolecular BioSystems, 2009
- The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sistersAmerican Journal of Obstetrics and Gynecology, 2008
- Pharmacological Inhibitors of Fatty Acid Synthase (FASN)-Catalyzed Endogenous Fatty Acid Biogenesis: A New Family of Anti-Cancer Agents?Current Pharmaceutical Biotechnology, 2006
- Health care resource use for uterine fibroid tumors in the United StatesAmerican Journal of Obstetrics and Gynecology, 2006
- Genomewide Linkage Study in 1,176 Affected Sister Pair Families Identifies a Significant Susceptibility Locus for Endometriosis on Chromosome 10q26American Journal of Human Genetics, 2005
- Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic miceOncogene, 2004
- The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancerCancer Cell, 2004
- Fatty Acid Synthase (Fas) Predictive Strength in Poorly Differentiated Early Breast CarcinomasTumori Journal, 1999
- Translocation breakpoints upstream of theHMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomasGenes, Chromosomes and Cancer, 1996